Proton Intelligence
Vancouver · Founded 2020
About Proton Intelligence
Proton Intelligence provides biomarker monitoring to manage chronic disease and save lives. The first biomarker is potassium, targeting hyperkalemia in chronic kidney disease (CKD) patients who have additional co-morbidities ProtonIntel was founded in 2020 and was headquartered in Vancouver, Canada.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: Seed
- Last round: Seed (Dec 2024)
- Website: https://www.protonintelligence.com/
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/proton-intelligence-116154 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.